Natco Pharma shares fall over 6% after weak Q1 results; Board approves fund raise of up to ₹2,000 crore

Natco Pharma shares fell sharply after weak Q1 earnings, with profit down 57% to Rs 206.5 crore. The board approved raising up to Rs 2,000 crore.

Leave a Reply

Your email address will not be published. Required fields are marked *